A Cleveland Clinic study found women remain underrepresented in cardiovascular clinical trials despite guidelines and legal requirements developed almost 30 years ago to ensure broader inclusivity, according to a report from the American College of Cardiology Cardiovascular Disease in Women Committee published today in the Journal of the American College of Cardiology.
Heart disease is the number one killer of women, yet most clinical trials involving heart medications and medical devices typically skew male.
This episode is an interview with Leslie Cho, MD, FACC, lead author of the study, a member of the ACC Cardiovascular Disease in Women Committee, and director of the Women’s Cardiovascular Center and section head of preventive cardiology and cardiac rehabilitation at Cleveland Clinic.
WEBSITES: clinicaltrials.gov
https://my.clevelandclinic.org/clinical-trials
